nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitaxentan—EDNRB—type 2 diabetes mellitus	0.232	0.528	CbGaD
Sitaxentan—EDNRA—type 2 diabetes mellitus	0.176	0.4	CbGaD
Sitaxentan—EDNRA—Irbesartan—type 2 diabetes mellitus	0.146	0.383	CbGbCtD
Sitaxentan—CYP3A4—type 2 diabetes mellitus	0.0318	0.0724	CbGaD
Sitaxentan—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0139	0.0363	CbGbCtD
Sitaxentan—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0136	0.0355	CbGbCtD
Sitaxentan—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0124	0.0325	CbGbCtD
Sitaxentan—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0118	0.0309	CbGbCtD
Sitaxentan—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0118	0.0309	CbGbCtD
Sitaxentan—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0115	0.0302	CbGbCtD
Sitaxentan—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0109	0.0285	CbGbCtD
Sitaxentan—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0105	0.0275	CbGbCtD
Sitaxentan—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.00981	0.0257	CbGbCtD
Sitaxentan—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.00981	0.0257	CbGbCtD
Sitaxentan—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00905	0.0237	CbGbCtD
Sitaxentan—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00885	0.0232	CbGbCtD
Sitaxentan—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00874	0.0229	CbGbCtD
Sitaxentan—CYP2C9—Valsartan—type 2 diabetes mellitus	0.008	0.0209	CbGbCtD
Sitaxentan—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00789	0.0207	CbGbCtD
Sitaxentan—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00743	0.0195	CbGbCtD
Sitaxentan—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00722	0.0189	CbGbCtD
Sitaxentan—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00713	0.0187	CbGbCtD
Sitaxentan—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00631	0.0165	CbGbCtD
Sitaxentan—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00604	0.0158	CbGbCtD
Sitaxentan—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0057	0.0149	CbGbCtD
Sitaxentan—CYP2C19—Losartan—type 2 diabetes mellitus	0.00552	0.0145	CbGbCtD
Sitaxentan—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00502	0.0131	CbGbCtD
Sitaxentan—CYP2C9—Losartan—type 2 diabetes mellitus	0.00459	0.012	CbGbCtD
Sitaxentan—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00432	0.0113	CbGbCtD
Sitaxentan—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00414	0.0109	CbGbCtD
Sitaxentan—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00414	0.0109	CbGbCtD
Sitaxentan—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00392	0.0103	CbGbCtD
Sitaxentan—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00292	0.00765	CbGbCtD
Sitaxentan—CYP3A4—Losartan—type 2 diabetes mellitus	0.00267	0.00699	CbGbCtD
Sitaxentan—EDNRB—islet of Langerhans—type 2 diabetes mellitus	0.000459	0.163	CbGeAlD
Sitaxentan—EDNRB—retina—type 2 diabetes mellitus	0.000392	0.139	CbGeAlD
Sitaxentan—EDNRB—pancreas—type 2 diabetes mellitus	0.000322	0.114	CbGeAlD
Sitaxentan—EDNRB—cortex of kidney—type 2 diabetes mellitus	0.000316	0.112	CbGeAlD
Sitaxentan—EDNRB—adipose tissue—type 2 diabetes mellitus	0.000292	0.104	CbGeAlD
Sitaxentan—EDNRA—cortex of kidney—type 2 diabetes mellitus	0.000261	0.0926	CbGeAlD
Sitaxentan—EDNRA—adipose tissue—type 2 diabetes mellitus	0.000242	0.0857	CbGeAlD
Sitaxentan—EDNRB—liver—type 2 diabetes mellitus	0.000205	0.0727	CbGeAlD
Sitaxentan—CYP2C9—cardiovascular system—type 2 diabetes mellitus	9.07e-05	0.0322	CbGeAlD
Sitaxentan—CYP2C19—liver—type 2 diabetes mellitus	7.24e-05	0.0257	CbGeAlD
Sitaxentan—CYP3A4—kidney—type 2 diabetes mellitus	6.77e-05	0.024	CbGeAlD
Sitaxentan—CYP2C9—liver—type 2 diabetes mellitus	5.61e-05	0.0199	CbGeAlD
Sitaxentan—Dermatitis—Glipizide—type 2 diabetes mellitus	4.58e-05	0.00041	CcSEcCtD
Sitaxentan—Oedema—Orlistat—type 2 diabetes mellitus	4.56e-05	0.000408	CcSEcCtD
Sitaxentan—Headache—Glipizide—type 2 diabetes mellitus	4.55e-05	0.000408	CcSEcCtD
Sitaxentan—Tremor—Irbesartan—type 2 diabetes mellitus	4.55e-05	0.000408	CcSEcCtD
Sitaxentan—Insomnia—Gliclazide—type 2 diabetes mellitus	4.54e-05	0.000407	CcSEcCtD
Sitaxentan—Infection—Orlistat—type 2 diabetes mellitus	4.53e-05	0.000406	CcSEcCtD
Sitaxentan—Nervous system disorder—Valsartan—type 2 diabetes mellitus	4.52e-05	0.000405	CcSEcCtD
Sitaxentan—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	4.52e-05	0.000405	CcSEcCtD
Sitaxentan—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	4.51e-05	0.000404	CcSEcCtD
Sitaxentan—Hepatitis—Ramipril—type 2 diabetes mellitus	4.5e-05	0.000403	CcSEcCtD
Sitaxentan—Anaemia—Irbesartan—type 2 diabetes mellitus	4.49e-05	0.000402	CcSEcCtD
Sitaxentan—Tension—Losartan—type 2 diabetes mellitus	4.49e-05	0.000402	CcSEcCtD
Sitaxentan—Dizziness—Glimepiride—type 2 diabetes mellitus	4.48e-05	0.000402	CcSEcCtD
Sitaxentan—Skin disorder—Valsartan—type 2 diabetes mellitus	4.48e-05	0.000401	CcSEcCtD
Sitaxentan—Nervous system disorder—Orlistat—type 2 diabetes mellitus	4.47e-05	0.000401	CcSEcCtD
Sitaxentan—Dizziness—Sitagliptin—type 2 diabetes mellitus	4.47e-05	0.0004	CcSEcCtD
Sitaxentan—Agitation—Irbesartan—type 2 diabetes mellitus	4.46e-05	0.0004	CcSEcCtD
Sitaxentan—Somnolence—Gliclazide—type 2 diabetes mellitus	4.46e-05	0.0004	CcSEcCtD
Sitaxentan—Urticaria—Glyburide—type 2 diabetes mellitus	4.44e-05	0.000398	CcSEcCtD
Sitaxentan—Nervousness—Losartan—type 2 diabetes mellitus	4.44e-05	0.000398	CcSEcCtD
Sitaxentan—Oedema peripheral—Ramipril—type 2 diabetes mellitus	4.44e-05	0.000397	CcSEcCtD
Sitaxentan—Skin disorder—Orlistat—type 2 diabetes mellitus	4.43e-05	0.000397	CcSEcCtD
Sitaxentan—Dyspepsia—Gliclazide—type 2 diabetes mellitus	4.42e-05	0.000396	CcSEcCtD
Sitaxentan—Anorexia—Valsartan—type 2 diabetes mellitus	4.4e-05	0.000394	CcSEcCtD
Sitaxentan—Muscle spasms—Losartan—type 2 diabetes mellitus	4.4e-05	0.000394	CcSEcCtD
Sitaxentan—Asthenia—Bromocriptine—type 2 diabetes mellitus	4.39e-05	0.000393	CcSEcCtD
Sitaxentan—Chest pain—Metformin—type 2 diabetes mellitus	4.38e-05	0.000393	CcSEcCtD
Sitaxentan—Malaise—Irbesartan—type 2 diabetes mellitus	4.38e-05	0.000392	CcSEcCtD
Sitaxentan—Vertigo—Irbesartan—type 2 diabetes mellitus	4.36e-05	0.000391	CcSEcCtD
Sitaxentan—Headache—Pioglitazone—type 2 diabetes mellitus	4.36e-05	0.000391	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	4.35e-05	0.00039	CcSEcCtD
Sitaxentan—Leukopenia—Irbesartan—type 2 diabetes mellitus	4.35e-05	0.00039	CcSEcCtD
Sitaxentan—Visual impairment—Ramipril—type 2 diabetes mellitus	4.34e-05	0.000389	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	4.34e-05	0.000388	CcSEcCtD
Sitaxentan—Discomfort—Metformin—type 2 diabetes mellitus	4.33e-05	0.000388	CcSEcCtD
Sitaxentan—Fatigue—Gliclazide—type 2 diabetes mellitus	4.33e-05	0.000388	CcSEcCtD
Sitaxentan—Nausea—Glipizide—type 2 diabetes mellitus	4.32e-05	0.000387	CcSEcCtD
Sitaxentan—Vomiting—Glimepiride—type 2 diabetes mellitus	4.31e-05	0.000386	CcSEcCtD
Sitaxentan—Hypotension—Valsartan—type 2 diabetes mellitus	4.31e-05	0.000386	CcSEcCtD
Sitaxentan—Vomiting—Sitagliptin—type 2 diabetes mellitus	4.3e-05	0.000385	CcSEcCtD
Sitaxentan—Constipation—Gliclazide—type 2 diabetes mellitus	4.29e-05	0.000385	CcSEcCtD
Sitaxentan—Pain—Gliclazide—type 2 diabetes mellitus	4.29e-05	0.000385	CcSEcCtD
Sitaxentan—Tremor—Losartan—type 2 diabetes mellitus	4.28e-05	0.000384	CcSEcCtD
Sitaxentan—CYP3A4—liver—type 2 diabetes mellitus	4.28e-05	0.0152	CbGeAlD
Sitaxentan—Rash—Glimepiride—type 2 diabetes mellitus	4.28e-05	0.000383	CcSEcCtD
Sitaxentan—Dermatitis—Glimepiride—type 2 diabetes mellitus	4.27e-05	0.000383	CcSEcCtD
Sitaxentan—Rash—Sitagliptin—type 2 diabetes mellitus	4.26e-05	0.000382	CcSEcCtD
Sitaxentan—Dermatitis—Sitagliptin—type 2 diabetes mellitus	4.26e-05	0.000381	CcSEcCtD
Sitaxentan—Headache—Glimepiride—type 2 diabetes mellitus	4.25e-05	0.000381	CcSEcCtD
Sitaxentan—Ill-defined disorder—Losartan—type 2 diabetes mellitus	4.24e-05	0.00038	CcSEcCtD
Sitaxentan—Headache—Sitagliptin—type 2 diabetes mellitus	4.23e-05	0.000379	CcSEcCtD
Sitaxentan—Anaemia—Losartan—type 2 diabetes mellitus	4.23e-05	0.000379	CcSEcCtD
Sitaxentan—Agitation—Losartan—type 2 diabetes mellitus	4.2e-05	0.000376	CcSEcCtD
Sitaxentan—Oedema—Metformin—type 2 diabetes mellitus	4.2e-05	0.000376	CcSEcCtD
Sitaxentan—Tinnitus—Ramipril—type 2 diabetes mellitus	4.2e-05	0.000376	CcSEcCtD
Sitaxentan—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	4.19e-05	0.000375	CcSEcCtD
Sitaxentan—Flushing—Ramipril—type 2 diabetes mellitus	4.18e-05	0.000374	CcSEcCtD
Sitaxentan—Infection—Metformin—type 2 diabetes mellitus	4.17e-05	0.000374	CcSEcCtD
Sitaxentan—Insomnia—Valsartan—type 2 diabetes mellitus	4.17e-05	0.000374	CcSEcCtD
Sitaxentan—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	4.14e-05	0.000371	CcSEcCtD
Sitaxentan—Chest pain—Irbesartan—type 2 diabetes mellitus	4.14e-05	0.000371	CcSEcCtD
Sitaxentan—Insomnia—Orlistat—type 2 diabetes mellitus	4.12e-05	0.000369	CcSEcCtD
Sitaxentan—Malaise—Losartan—type 2 diabetes mellitus	4.12e-05	0.000369	CcSEcCtD
Sitaxentan—Hypersensitivity—Glyburide—type 2 diabetes mellitus	4.12e-05	0.000369	CcSEcCtD
Sitaxentan—Nervous system disorder—Metformin—type 2 diabetes mellitus	4.12e-05	0.000369	CcSEcCtD
Sitaxentan—Thrombocytopenia—Metformin—type 2 diabetes mellitus	4.11e-05	0.000369	CcSEcCtD
Sitaxentan—Vertigo—Losartan—type 2 diabetes mellitus	4.11e-05	0.000368	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	4.11e-05	0.000368	CcSEcCtD
Sitaxentan—Somnolence—Valsartan—type 2 diabetes mellitus	4.1e-05	0.000367	CcSEcCtD
Sitaxentan—Leukopenia—Losartan—type 2 diabetes mellitus	4.09e-05	0.000367	CcSEcCtD
Sitaxentan—Discomfort—Irbesartan—type 2 diabetes mellitus	4.09e-05	0.000366	CcSEcCtD
Sitaxentan—Skin disorder—Metformin—type 2 diabetes mellitus	4.08e-05	0.000366	CcSEcCtD
Sitaxentan—Immune system disorder—Ramipril—type 2 diabetes mellitus	4.07e-05	0.000364	CcSEcCtD
Sitaxentan—Dyspepsia—Valsartan—type 2 diabetes mellitus	4.06e-05	0.000364	CcSEcCtD
Sitaxentan—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	4.06e-05	0.000364	CcSEcCtD
Sitaxentan—Dizziness—Bromocriptine—type 2 diabetes mellitus	4.05e-05	0.000362	CcSEcCtD
Sitaxentan—Dry mouth—Irbesartan—type 2 diabetes mellitus	4.04e-05	0.000362	CcSEcCtD
Sitaxentan—Nausea—Glimepiride—type 2 diabetes mellitus	4.03e-05	0.000361	CcSEcCtD
Sitaxentan—Nausea—Sitagliptin—type 2 diabetes mellitus	4.01e-05	0.00036	CcSEcCtD
Sitaxentan—Dyspepsia—Orlistat—type 2 diabetes mellitus	4.01e-05	0.00036	CcSEcCtD
Sitaxentan—Asthenia—Glyburide—type 2 diabetes mellitus	4.01e-05	0.000359	CcSEcCtD
Sitaxentan—Decreased appetite—Valsartan—type 2 diabetes mellitus	4.01e-05	0.000359	CcSEcCtD
Sitaxentan—Anorexia—Metformin—type 2 diabetes mellitus	4e-05	0.000359	CcSEcCtD
Sitaxentan—Urticaria—Gliclazide—type 2 diabetes mellitus	3.99e-05	0.000357	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	3.98e-05	0.000357	CcSEcCtD
Sitaxentan—Alopecia—Ramipril—type 2 diabetes mellitus	3.98e-05	0.000357	CcSEcCtD
Sitaxentan—Fatigue—Valsartan—type 2 diabetes mellitus	3.98e-05	0.000356	CcSEcCtD
Sitaxentan—Body temperature increased—Gliclazide—type 2 diabetes mellitus	3.97e-05	0.000356	CcSEcCtD
Sitaxentan—Oedema—Irbesartan—type 2 diabetes mellitus	3.96e-05	0.000355	CcSEcCtD
Sitaxentan—Decreased appetite—Orlistat—type 2 diabetes mellitus	3.96e-05	0.000355	CcSEcCtD
Sitaxentan—Mental disorder—Ramipril—type 2 diabetes mellitus	3.95e-05	0.000353	CcSEcCtD
Sitaxentan—Constipation—Valsartan—type 2 diabetes mellitus	3.95e-05	0.000353	CcSEcCtD
Sitaxentan—Infection—Irbesartan—type 2 diabetes mellitus	3.94e-05	0.000353	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	3.94e-05	0.000353	CcSEcCtD
Sitaxentan—Fatigue—Orlistat—type 2 diabetes mellitus	3.93e-05	0.000352	CcSEcCtD
Sitaxentan—Hypotension—Metformin—type 2 diabetes mellitus	3.93e-05	0.000352	CcSEcCtD
Sitaxentan—Malnutrition—Ramipril—type 2 diabetes mellitus	3.92e-05	0.000351	CcSEcCtD
Sitaxentan—Pain—Orlistat—type 2 diabetes mellitus	3.9e-05	0.000349	CcSEcCtD
Sitaxentan—Chest pain—Losartan—type 2 diabetes mellitus	3.89e-05	0.000349	CcSEcCtD
Sitaxentan—Vomiting—Bromocriptine—type 2 diabetes mellitus	3.89e-05	0.000348	CcSEcCtD
Sitaxentan—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	3.89e-05	0.000348	CcSEcCtD
Sitaxentan—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	3.88e-05	0.000348	CcSEcCtD
Sitaxentan—Tachycardia—Irbesartan—type 2 diabetes mellitus	3.87e-05	0.000347	CcSEcCtD
Sitaxentan—Rash—Bromocriptine—type 2 diabetes mellitus	3.86e-05	0.000346	CcSEcCtD
Sitaxentan—Dermatitis—Bromocriptine—type 2 diabetes mellitus	3.85e-05	0.000345	CcSEcCtD
Sitaxentan—Skin disorder—Irbesartan—type 2 diabetes mellitus	3.85e-05	0.000345	CcSEcCtD
Sitaxentan—Tension—Ramipril—type 2 diabetes mellitus	3.85e-05	0.000345	CcSEcCtD
Sitaxentan—Discomfort—Losartan—type 2 diabetes mellitus	3.85e-05	0.000345	CcSEcCtD
Sitaxentan—Headache—Bromocriptine—type 2 diabetes mellitus	3.83e-05	0.000343	CcSEcCtD
Sitaxentan—Diarrhoea—Glyburide—type 2 diabetes mellitus	3.83e-05	0.000343	CcSEcCtD
Sitaxentan—Nervousness—Ramipril—type 2 diabetes mellitus	3.81e-05	0.000341	CcSEcCtD
Sitaxentan—Dry mouth—Losartan—type 2 diabetes mellitus	3.81e-05	0.000341	CcSEcCtD
Sitaxentan—Anorexia—Irbesartan—type 2 diabetes mellitus	3.78e-05	0.000339	CcSEcCtD
Sitaxentan—Muscle spasms—Ramipril—type 2 diabetes mellitus	3.77e-05	0.000338	CcSEcCtD
Sitaxentan—Confusional state—Losartan—type 2 diabetes mellitus	3.76e-05	0.000337	CcSEcCtD
Sitaxentan—Feeling abnormal—Orlistat—type 2 diabetes mellitus	3.76e-05	0.000337	CcSEcCtD
Sitaxentan—Somnolence—Metformin—type 2 diabetes mellitus	3.73e-05	0.000335	CcSEcCtD
Sitaxentan—Oedema—Losartan—type 2 diabetes mellitus	3.73e-05	0.000334	CcSEcCtD
Sitaxentan—Infection—Losartan—type 2 diabetes mellitus	3.71e-05	0.000332	CcSEcCtD
Sitaxentan—Hypotension—Irbesartan—type 2 diabetes mellitus	3.7e-05	0.000332	CcSEcCtD
Sitaxentan—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	3.7e-05	0.000331	CcSEcCtD
Sitaxentan—Dyspepsia—Metformin—type 2 diabetes mellitus	3.7e-05	0.000331	CcSEcCtD
Sitaxentan—Tremor—Ramipril—type 2 diabetes mellitus	3.67e-05	0.000329	CcSEcCtD
Sitaxentan—Urticaria—Valsartan—type 2 diabetes mellitus	3.66e-05	0.000328	CcSEcCtD
Sitaxentan—Nervous system disorder—Losartan—type 2 diabetes mellitus	3.66e-05	0.000328	CcSEcCtD
Sitaxentan—Thrombocytopenia—Losartan—type 2 diabetes mellitus	3.65e-05	0.000327	CcSEcCtD
Sitaxentan—Decreased appetite—Metformin—type 2 diabetes mellitus	3.65e-05	0.000327	CcSEcCtD
Sitaxentan—Tachycardia—Losartan—type 2 diabetes mellitus	3.64e-05	0.000326	CcSEcCtD
Sitaxentan—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	3.64e-05	0.000326	CcSEcCtD
Sitaxentan—Nausea—Bromocriptine—type 2 diabetes mellitus	3.63e-05	0.000326	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	3.63e-05	0.000325	CcSEcCtD
Sitaxentan—Fatigue—Metformin—type 2 diabetes mellitus	3.62e-05	0.000325	CcSEcCtD
Sitaxentan—Urticaria—Orlistat—type 2 diabetes mellitus	3.62e-05	0.000324	CcSEcCtD
Sitaxentan—Body temperature increased—Orlistat—type 2 diabetes mellitus	3.6e-05	0.000323	CcSEcCtD
Sitaxentan—Asthenia—Gliclazide—type 2 diabetes mellitus	3.6e-05	0.000323	CcSEcCtD
Sitaxentan—Agitation—Ramipril—type 2 diabetes mellitus	3.6e-05	0.000323	CcSEcCtD
Sitaxentan—Constipation—Metformin—type 2 diabetes mellitus	3.59e-05	0.000322	CcSEcCtD
Sitaxentan—Anorexia—Losartan—type 2 diabetes mellitus	3.56e-05	0.000319	CcSEcCtD
Sitaxentan—Vomiting—Glyburide—type 2 diabetes mellitus	3.56e-05	0.000319	CcSEcCtD
Sitaxentan—Malaise—Ramipril—type 2 diabetes mellitus	3.54e-05	0.000317	CcSEcCtD
Sitaxentan—Rash—Glyburide—type 2 diabetes mellitus	3.53e-05	0.000316	CcSEcCtD
Sitaxentan—Somnolence—Irbesartan—type 2 diabetes mellitus	3.52e-05	0.000316	CcSEcCtD
Sitaxentan—Dermatitis—Glyburide—type 2 diabetes mellitus	3.52e-05	0.000316	CcSEcCtD
Sitaxentan—Vertigo—Ramipril—type 2 diabetes mellitus	3.52e-05	0.000316	CcSEcCtD
Sitaxentan—Leukopenia—Ramipril—type 2 diabetes mellitus	3.51e-05	0.000314	CcSEcCtD
Sitaxentan—Headache—Glyburide—type 2 diabetes mellitus	3.5e-05	0.000314	CcSEcCtD
Sitaxentan—Dyspepsia—Irbesartan—type 2 diabetes mellitus	3.49e-05	0.000313	CcSEcCtD
Sitaxentan—Hypotension—Losartan—type 2 diabetes mellitus	3.49e-05	0.000312	CcSEcCtD
Sitaxentan—Feeling abnormal—Metformin—type 2 diabetes mellitus	3.46e-05	0.00031	CcSEcCtD
Sitaxentan—Decreased appetite—Irbesartan—type 2 diabetes mellitus	3.45e-05	0.000309	CcSEcCtD
Sitaxentan—Diarrhoea—Gliclazide—type 2 diabetes mellitus	3.44e-05	0.000308	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	3.42e-05	0.000307	CcSEcCtD
Sitaxentan—Fatigue—Irbesartan—type 2 diabetes mellitus	3.42e-05	0.000306	CcSEcCtD
Sitaxentan—Hypersensitivity—Valsartan—type 2 diabetes mellitus	3.4e-05	0.000305	CcSEcCtD
Sitaxentan—Pain—Irbesartan—type 2 diabetes mellitus	3.39e-05	0.000304	CcSEcCtD
Sitaxentan—Constipation—Irbesartan—type 2 diabetes mellitus	3.39e-05	0.000304	CcSEcCtD
Sitaxentan—Insomnia—Losartan—type 2 diabetes mellitus	3.37e-05	0.000302	CcSEcCtD
Sitaxentan—Hypersensitivity—Orlistat—type 2 diabetes mellitus	3.36e-05	0.000301	CcSEcCtD
Sitaxentan—Urticaria—Metformin—type 2 diabetes mellitus	3.34e-05	0.000299	CcSEcCtD
Sitaxentan—Chest pain—Ramipril—type 2 diabetes mellitus	3.34e-05	0.000299	CcSEcCtD
Sitaxentan—Nausea—Glyburide—type 2 diabetes mellitus	3.32e-05	0.000298	CcSEcCtD
Sitaxentan—Dizziness—Gliclazide—type 2 diabetes mellitus	3.32e-05	0.000297	CcSEcCtD
Sitaxentan—Somnolence—Losartan—type 2 diabetes mellitus	3.32e-05	0.000297	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	3.31e-05	0.000297	CcSEcCtD
Sitaxentan—Asthenia—Valsartan—type 2 diabetes mellitus	3.31e-05	0.000297	CcSEcCtD
Sitaxentan—Discomfort—Ramipril—type 2 diabetes mellitus	3.3e-05	0.000295	CcSEcCtD
Sitaxentan—Dyspepsia—Losartan—type 2 diabetes mellitus	3.28e-05	0.000294	CcSEcCtD
Sitaxentan—Asthenia—Orlistat—type 2 diabetes mellitus	3.27e-05	0.000293	CcSEcCtD
Sitaxentan—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	3.27e-05	0.000293	CcSEcCtD
Sitaxentan—Dry mouth—Ramipril—type 2 diabetes mellitus	3.26e-05	0.000292	CcSEcCtD
Sitaxentan—Decreased appetite—Losartan—type 2 diabetes mellitus	3.24e-05	0.000291	CcSEcCtD
Sitaxentan—Confusional state—Ramipril—type 2 diabetes mellitus	3.23e-05	0.000289	CcSEcCtD
Sitaxentan—Fatigue—Losartan—type 2 diabetes mellitus	3.22e-05	0.000288	CcSEcCtD
Sitaxentan—Oedema—Ramipril—type 2 diabetes mellitus	3.2e-05	0.000287	CcSEcCtD
Sitaxentan—Vomiting—Gliclazide—type 2 diabetes mellitus	3.19e-05	0.000286	CcSEcCtD
Sitaxentan—Constipation—Losartan—type 2 diabetes mellitus	3.19e-05	0.000286	CcSEcCtD
Sitaxentan—Pain—Losartan—type 2 diabetes mellitus	3.19e-05	0.000286	CcSEcCtD
Sitaxentan—Rash—Gliclazide—type 2 diabetes mellitus	3.17e-05	0.000284	CcSEcCtD
Sitaxentan—Dermatitis—Gliclazide—type 2 diabetes mellitus	3.16e-05	0.000283	CcSEcCtD
Sitaxentan—Diarrhoea—Valsartan—type 2 diabetes mellitus	3.16e-05	0.000283	CcSEcCtD
Sitaxentan—Urticaria—Irbesartan—type 2 diabetes mellitus	3.15e-05	0.000282	CcSEcCtD
Sitaxentan—Headache—Gliclazide—type 2 diabetes mellitus	3.15e-05	0.000282	CcSEcCtD
Sitaxentan—Nervous system disorder—Ramipril—type 2 diabetes mellitus	3.14e-05	0.000281	CcSEcCtD
Sitaxentan—Body temperature increased—Irbesartan—type 2 diabetes mellitus	3.13e-05	0.000281	CcSEcCtD
Sitaxentan—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	3.13e-05	0.000281	CcSEcCtD
Sitaxentan—Tachycardia—Ramipril—type 2 diabetes mellitus	3.12e-05	0.00028	CcSEcCtD
Sitaxentan—Diarrhoea—Orlistat—type 2 diabetes mellitus	3.12e-05	0.000279	CcSEcCtD
Sitaxentan—Skin disorder—Ramipril—type 2 diabetes mellitus	3.11e-05	0.000278	CcSEcCtD
Sitaxentan—Feeling abnormal—Losartan—type 2 diabetes mellitus	3.07e-05	0.000275	CcSEcCtD
Sitaxentan—Dizziness—Valsartan—type 2 diabetes mellitus	3.05e-05	0.000273	CcSEcCtD
Sitaxentan—Anorexia—Ramipril—type 2 diabetes mellitus	3.05e-05	0.000273	CcSEcCtD
Sitaxentan—Dizziness—Orlistat—type 2 diabetes mellitus	3.01e-05	0.00027	CcSEcCtD
Sitaxentan—Asthenia—Metformin—type 2 diabetes mellitus	3.01e-05	0.00027	CcSEcCtD
Sitaxentan—Hypotension—Ramipril—type 2 diabetes mellitus	2.99e-05	0.000268	CcSEcCtD
Sitaxentan—Nausea—Gliclazide—type 2 diabetes mellitus	2.98e-05	0.000267	CcSEcCtD
Sitaxentan—Urticaria—Losartan—type 2 diabetes mellitus	2.96e-05	0.000266	CcSEcCtD
Sitaxentan—Body temperature increased—Losartan—type 2 diabetes mellitus	2.95e-05	0.000264	CcSEcCtD
Sitaxentan—Vomiting—Valsartan—type 2 diabetes mellitus	2.93e-05	0.000263	CcSEcCtD
Sitaxentan—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	2.92e-05	0.000262	CcSEcCtD
Sitaxentan—Rash—Valsartan—type 2 diabetes mellitus	2.91e-05	0.000261	CcSEcCtD
Sitaxentan—Dermatitis—Valsartan—type 2 diabetes mellitus	2.91e-05	0.00026	CcSEcCtD
Sitaxentan—Vomiting—Orlistat—type 2 diabetes mellitus	2.9e-05	0.00026	CcSEcCtD
Sitaxentan—Insomnia—Ramipril—type 2 diabetes mellitus	2.89e-05	0.000259	CcSEcCtD
Sitaxentan—Headache—Valsartan—type 2 diabetes mellitus	2.89e-05	0.000259	CcSEcCtD
Sitaxentan—Diarrhoea—Metformin—type 2 diabetes mellitus	2.87e-05	0.000258	CcSEcCtD
Sitaxentan—Rash—Orlistat—type 2 diabetes mellitus	2.87e-05	0.000258	CcSEcCtD
Sitaxentan—Dermatitis—Orlistat—type 2 diabetes mellitus	2.87e-05	0.000257	CcSEcCtD
Sitaxentan—Headache—Orlistat—type 2 diabetes mellitus	2.86e-05	0.000256	CcSEcCtD
Sitaxentan—Asthenia—Irbesartan—type 2 diabetes mellitus	2.84e-05	0.000255	CcSEcCtD
Sitaxentan—Somnolence—Ramipril—type 2 diabetes mellitus	2.84e-05	0.000255	CcSEcCtD
Sitaxentan—Dyspepsia—Ramipril—type 2 diabetes mellitus	2.82e-05	0.000252	CcSEcCtD
Sitaxentan—Decreased appetite—Ramipril—type 2 diabetes mellitus	2.78e-05	0.000249	CcSEcCtD
Sitaxentan—Dizziness—Metformin—type 2 diabetes mellitus	2.78e-05	0.000249	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	2.76e-05	0.000247	CcSEcCtD
Sitaxentan—Fatigue—Ramipril—type 2 diabetes mellitus	2.76e-05	0.000247	CcSEcCtD
Sitaxentan—Hypersensitivity—Losartan—type 2 diabetes mellitus	2.75e-05	0.000246	CcSEcCtD
Sitaxentan—Nausea—Valsartan—type 2 diabetes mellitus	2.74e-05	0.000246	CcSEcCtD
Sitaxentan—Constipation—Ramipril—type 2 diabetes mellitus	2.74e-05	0.000245	CcSEcCtD
Sitaxentan—Diarrhoea—Irbesartan—type 2 diabetes mellitus	2.71e-05	0.000243	CcSEcCtD
Sitaxentan—Nausea—Orlistat—type 2 diabetes mellitus	2.71e-05	0.000243	CcSEcCtD
Sitaxentan—Asthenia—Losartan—type 2 diabetes mellitus	2.68e-05	0.00024	CcSEcCtD
Sitaxentan—Vomiting—Metformin—type 2 diabetes mellitus	2.67e-05	0.000239	CcSEcCtD
Sitaxentan—Rash—Metformin—type 2 diabetes mellitus	2.65e-05	0.000237	CcSEcCtD
Sitaxentan—Dermatitis—Metformin—type 2 diabetes mellitus	2.65e-05	0.000237	CcSEcCtD
Sitaxentan—Feeling abnormal—Ramipril—type 2 diabetes mellitus	2.64e-05	0.000236	CcSEcCtD
Sitaxentan—Headache—Metformin—type 2 diabetes mellitus	2.63e-05	0.000236	CcSEcCtD
Sitaxentan—Dizziness—Irbesartan—type 2 diabetes mellitus	2.62e-05	0.000235	CcSEcCtD
Sitaxentan—Diarrhoea—Losartan—type 2 diabetes mellitus	2.55e-05	0.000229	CcSEcCtD
Sitaxentan—Urticaria—Ramipril—type 2 diabetes mellitus	2.54e-05	0.000228	CcSEcCtD
Sitaxentan—Body temperature increased—Ramipril—type 2 diabetes mellitus	2.53e-05	0.000227	CcSEcCtD
Sitaxentan—Vomiting—Irbesartan—type 2 diabetes mellitus	2.52e-05	0.000226	CcSEcCtD
Sitaxentan—Rash—Irbesartan—type 2 diabetes mellitus	2.5e-05	0.000224	CcSEcCtD
Sitaxentan—Dermatitis—Irbesartan—type 2 diabetes mellitus	2.5e-05	0.000224	CcSEcCtD
Sitaxentan—Nausea—Metformin—type 2 diabetes mellitus	2.5e-05	0.000224	CcSEcCtD
Sitaxentan—Headache—Irbesartan—type 2 diabetes mellitus	2.48e-05	0.000223	CcSEcCtD
Sitaxentan—Dizziness—Losartan—type 2 diabetes mellitus	2.47e-05	0.000221	CcSEcCtD
Sitaxentan—Vomiting—Losartan—type 2 diabetes mellitus	2.37e-05	0.000213	CcSEcCtD
Sitaxentan—Hypersensitivity—Ramipril—type 2 diabetes mellitus	2.36e-05	0.000211	CcSEcCtD
Sitaxentan—Nausea—Irbesartan—type 2 diabetes mellitus	2.35e-05	0.000211	CcSEcCtD
Sitaxentan—Rash—Losartan—type 2 diabetes mellitus	2.35e-05	0.000211	CcSEcCtD
Sitaxentan—Dermatitis—Losartan—type 2 diabetes mellitus	2.35e-05	0.000211	CcSEcCtD
Sitaxentan—Headache—Losartan—type 2 diabetes mellitus	2.34e-05	0.000209	CcSEcCtD
Sitaxentan—Asthenia—Ramipril—type 2 diabetes mellitus	2.3e-05	0.000206	CcSEcCtD
Sitaxentan—Nausea—Losartan—type 2 diabetes mellitus	2.22e-05	0.000199	CcSEcCtD
Sitaxentan—Diarrhoea—Ramipril—type 2 diabetes mellitus	2.19e-05	0.000196	CcSEcCtD
Sitaxentan—Dizziness—Ramipril—type 2 diabetes mellitus	2.12e-05	0.00019	CcSEcCtD
Sitaxentan—Vomiting—Ramipril—type 2 diabetes mellitus	2.03e-05	0.000182	CcSEcCtD
Sitaxentan—Rash—Ramipril—type 2 diabetes mellitus	2.02e-05	0.000181	CcSEcCtD
Sitaxentan—Dermatitis—Ramipril—type 2 diabetes mellitus	2.02e-05	0.000181	CcSEcCtD
Sitaxentan—Headache—Ramipril—type 2 diabetes mellitus	2e-05	0.00018	CcSEcCtD
Sitaxentan—Nausea—Ramipril—type 2 diabetes mellitus	1.9e-05	0.00017	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—IGF1—type 2 diabetes mellitus	7.04e-06	0.00011	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—AKT2—type 2 diabetes mellitus	7.03e-06	0.00011	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—EGFR—type 2 diabetes mellitus	7e-06	0.000109	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—UCP2—type 2 diabetes mellitus	6.95e-06	0.000109	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—UCP3—type 2 diabetes mellitus	6.95e-06	0.000109	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—HSD11B1—type 2 diabetes mellitus	6.95e-06	0.000109	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.94e-06	0.000108	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	6.85e-06	0.000107	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	6.85e-06	0.000107	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CBS—type 2 diabetes mellitus	6.82e-06	0.000107	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ABCC8—type 2 diabetes mellitus	6.82e-06	0.000107	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	6.74e-06	0.000105	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.68e-06	0.000104	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—SRC—type 2 diabetes mellitus	6.59e-06	0.000103	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—COX2—type 2 diabetes mellitus	6.56e-06	0.000103	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—SLC5A2—type 2 diabetes mellitus	6.56e-06	0.000103	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PCK1—type 2 diabetes mellitus	6.54e-06	0.000102	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	6.49e-06	0.000101	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	6.49e-06	0.000101	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—NCOA6—type 2 diabetes mellitus	6.45e-06	0.000101	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	6.45e-06	0.000101	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	6.44e-06	0.000101	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.42e-06	0.0001	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.38e-06	9.97e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.38e-06	9.97e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—UCP2—type 2 diabetes mellitus	6.34e-06	9.91e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—HSD11B1—type 2 diabetes mellitus	6.34e-06	9.91e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—UCP3—type 2 diabetes mellitus	6.34e-06	9.91e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	6.28e-06	9.81e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	6.19e-06	9.67e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	6.15e-06	9.6e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—HK1—type 2 diabetes mellitus	6.12e-06	9.57e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	6.12e-06	9.56e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—RELA—type 2 diabetes mellitus	6e-06	9.38e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PCK1—type 2 diabetes mellitus	5.96e-06	9.31e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—LPA—type 2 diabetes mellitus	5.91e-06	9.24e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GCKR—type 2 diabetes mellitus	5.91e-06	9.24e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—KCNJ11—type 2 diabetes mellitus	5.91e-06	9.24e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—HSD3B2—type 2 diabetes mellitus	5.91e-06	9.24e-05	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.89e-06	9.21e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	5.87e-06	9.17e-05	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.78e-06	9.03e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	5.73e-06	8.95e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	5.71e-06	8.93e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	5.71e-06	8.93e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	5.69e-06	8.88e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ALDOB—type 2 diabetes mellitus	5.67e-06	8.86e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—HK1—type 2 diabetes mellitus	5.58e-06	8.72e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	5.58e-06	8.71e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	5.52e-06	8.62e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	5.52e-06	8.62e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	5.52e-06	8.62e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	5.52e-06	8.62e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	5.52e-06	8.62e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	5.51e-06	8.6e-05	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.47e-06	8.54e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.42e-06	8.46e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	5.39e-06	8.43e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—KCNJ11—type 2 diabetes mellitus	5.39e-06	8.42e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GCKR—type 2 diabetes mellitus	5.39e-06	8.42e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—HSD3B2—type 2 diabetes mellitus	5.39e-06	8.42e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—LPA—type 2 diabetes mellitus	5.39e-06	8.42e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.38e-06	8.41e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	5.34e-06	8.35e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	5.33e-06	8.33e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GLP1R—type 2 diabetes mellitus	5.27e-06	8.23e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	5.18e-06	8.1e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	5.17e-06	8.08e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.12e-06	8e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.06e-06	7.91e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	5.05e-06	7.89e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	5.05e-06	7.89e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	5.02e-06	7.84e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.96e-06	7.76e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—SLC2A2—type 2 diabetes mellitus	4.92e-06	7.69e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	4.92e-06	7.69e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	4.92e-06	7.68e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	4.86e-06	7.6e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CPT1A—type 2 diabetes mellitus	4.82e-06	7.53e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—MTR—type 2 diabetes mellitus	4.82e-06	7.53e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	4.81e-06	7.51e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—NAMPT—type 2 diabetes mellitus	4.73e-06	7.39e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—SRC—type 2 diabetes mellitus	4.72e-06	7.37e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	4.7e-06	7.34e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—LIPC—type 2 diabetes mellitus	4.7e-06	7.34e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—HBA1—type 2 diabetes mellitus	4.7e-06	7.34e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GCK—type 2 diabetes mellitus	4.7e-06	7.34e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	4.69e-06	7.33e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	4.69e-06	7.33e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	4.69e-06	7.33e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CYP11A1—type 2 diabetes mellitus	4.67e-06	7.29e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.6e-06	7.18e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—SLC9A1—type 2 diabetes mellitus	4.58e-06	7.16e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CETP—type 2 diabetes mellitus	4.53e-06	7.08e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	4.5e-06	7.03e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	4.5e-06	7.03e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	4.49e-06	7.01e-05	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IL6—type 2 diabetes mellitus	4.44e-06	6.94e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	4.39e-06	6.87e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	4.39e-06	6.87e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	4.33e-06	6.77e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	4.33e-06	6.77e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	4.31e-06	6.73e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	4.28e-06	6.7e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	4.28e-06	6.69e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	4.28e-06	6.69e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	4.28e-06	6.69e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	4.26e-06	6.65e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	4.25e-06	6.65e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	4.23e-06	6.6e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.22e-06	6.59e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PSMD6—type 2 diabetes mellitus	4.21e-06	6.58e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—SREBF1—type 2 diabetes mellitus	4.21e-06	6.58e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—SNAP25—type 2 diabetes mellitus	4.21e-06	6.58e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	4.18e-06	6.53e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	4.18e-06	6.53e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	4.18e-06	6.53e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	4.18e-06	6.53e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.14e-06	6.46e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	4.14e-06	6.46e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	4.13e-06	6.46e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	4.1e-06	6.4e-05	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.1e-06	6.4e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.04e-06	6.32e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	4.01e-06	6.27e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	3.93e-06	6.14e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	3.85e-06	6.02e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	3.85e-06	6.02e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	3.84e-06	6e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	3.84e-06	6e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	3.84e-06	6e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	3.81e-06	5.95e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	3.81e-06	5.95e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	3.77e-06	5.89e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	3.74e-06	5.84e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	3.72e-06	5.81e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.7e-06	5.78e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.69e-06	5.76e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	3.68e-06	5.75e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	3.66e-06	5.71e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	3.65e-06	5.71e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	3.65e-06	5.71e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	3.56e-06	5.56e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	3.56e-06	5.56e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	3.56e-06	5.56e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	3.56e-06	5.56e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	3.51e-06	5.49e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	3.47e-06	5.43e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	3.47e-06	5.43e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	3.41e-06	5.33e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	3.39e-06	5.29e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.37e-06	5.27e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	3.33e-06	5.2e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	3.33e-06	5.2e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IL6—type 2 diabetes mellitus	3.18e-06	4.97e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	3.17e-06	4.95e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.15e-06	4.92e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	3.15e-06	4.92e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	3.13e-06	4.9e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	3.09e-06	4.83e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	3e-06	4.69e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	2.96e-06	4.62e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.93e-06	4.58e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	2.92e-06	4.56e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	2.9e-06	4.53e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	2.9e-06	4.53e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	2.87e-06	4.49e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.87e-06	4.49e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	2.87e-06	4.48e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	2.86e-06	4.47e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	2.84e-06	4.44e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	2.82e-06	4.41e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	2.82e-06	4.41e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	2.82e-06	4.41e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	2.82e-06	4.41e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	2.81e-06	4.39e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	2.81e-06	4.38e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	2.8e-06	4.37e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	2.76e-06	4.31e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	2.74e-06	4.28e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	2.73e-06	4.26e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	2.72e-06	4.26e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	2.69e-06	4.2e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	2.66e-06	4.16e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	2.61e-06	4.08e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	2.58e-06	4.03e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	2.56e-06	4e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	2.55e-06	3.98e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	2.53e-06	3.96e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	2.53e-06	3.96e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	2.53e-06	3.96e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	2.53e-06	3.96e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	2.49e-06	3.89e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	2.48e-06	3.88e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	2.46e-06	3.85e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	2.45e-06	3.83e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	2.45e-06	3.83e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.41e-06	3.77e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	2.41e-06	3.77e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	2.4e-06	3.75e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	2.38e-06	3.71e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	2.35e-06	3.68e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.32e-06	3.62e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	2.31e-06	3.61e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.29e-06	3.58e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.29e-06	3.58e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	2.24e-06	3.49e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	2.2e-06	3.44e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.2e-06	3.43e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.2e-06	3.43e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	2.19e-06	3.42e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	2.17e-06	3.38e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	2.09e-06	3.27e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	2.05e-06	3.21e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	1.91e-06	2.98e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.89e-06	2.96e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.89e-06	2.96e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.88e-06	2.94e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	1.88e-06	2.94e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	1.87e-06	2.92e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.86e-06	2.91e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.81e-06	2.82e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	1.8e-06	2.81e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	1.8e-06	2.81e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.76e-06	2.74e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.72e-06	2.69e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	1.72e-06	2.68e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.69e-06	2.64e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.68e-06	2.63e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	1.65e-06	2.57e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.64e-06	2.56e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.64e-06	2.56e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.64e-06	2.56e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.62e-06	2.53e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.55e-06	2.42e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.52e-06	2.38e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.5e-06	2.35e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.47e-06	2.3e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.45e-06	2.27e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.44e-06	2.26e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.43e-06	2.23e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.26e-06	1.97e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.23e-06	1.93e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.13e-06	1.77e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.08e-06	1.69e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.08e-06	1.69e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	9.9e-07	1.55e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	8.27e-07	1.29e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	7.54e-07	1.18e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	4.98e-07	7.77e-06	CbGpPWpGaD
